| Literature DB >> 32118084 |
Roald Bahr, Ben Clarsen, Wayne Derman, Jiri Dvorak, Carolyn A Emery, Caroline F Finch, Martin Hägglund, Astrid Junge, Simon Kemp, Karim M Khan, Stephen W Marshall, Willem Meeuwisse, Margo Mountjoy, John W Orchard, Babette Pluim, Kenneth L Quarrie, Bruce Reider, Martin Schwellnus, Torbjørn Soligard, Keith A Stokes, Toomas Timpka, Evert Verhagen, Abhinav Bindra, Richard Budgett, Lars Engebretsen, Uğur Erdener, Karim Chamari.
Abstract
BACKGROUND: Injury and illness surveillance, and epidemiological studies, are fundamental elements of concerted efforts to protect the health of the athlete. To encourage consistency in the definitions and methodology used, and to enable data across studies to be compared, research groups have published 11 sport- or setting-specific consensus statements on sports injury (and, eventually, illnesses) epidemiology to date.Entities:
Keywords: STROBE; epidemiologic methods; illness; injuries; surveillance
Year: 2020 PMID: 32118084 PMCID: PMC7029549 DOI: 10.1177/2325967120902908
Source DB: PubMed Journal: Orthop J Sports Med ISSN: 2325-9671
Figure 1.Distribution of health problems by consequences (not to scale). Adapted from Clarsen and Bahr.[14]
Examples: Assessment of Mode of Onset
| Mechanism | Presentation | Example |
|---|---|---|
| Acute | Sudden onset | 1. A sprinter pulls up suddenly in a race, stops, and hobbles a few steps in obvious pain with a hamstring injury. |
| Repetitive | Sudden onset | 2. A gymnast experiences a frank tibial and fibular fracture on landing from a vault; computed tomography imaging reveals pre-existing morphological changes consistent with bone stress, that is, a stress fracture. |
| Repetitive | Gradual onset | 3. A swimmer experiences a gradual increase in shoulder pain over the course of a season; diagnosed as rotator cuff tendinopathy on magnetic resonance imaging. |
Examples: Classification of Contact as a Mechanism for Sudden-Onset Injuries
| Injury | Type of Contact | Example |
|---|---|---|
| Noncontact | ||
| None | No evidence of disruption or perturbation of the player’s movement pattern | ACL tear in a basketball player landing with knee valgus/rotation after a jump, with no contact with other players |
| Contact | ||
| Indirect | Through another athlete | ACL tear in a handball player landing out of balance after being pushed on her shoulder by an opponent while in the air |
| Indirect | Through an object | Downhill skier suffers a concussion from a crash after being knocked off balance, hitting the gate with his knee |
| Contact | ||
| Direct | With another athlete | ACL tear in a football player from a direct tackle to the anterior aspect of the knee, forcing the knee into hyperextension |
| Direct | With an object | Volleyball player being hit in the face by a spiked ball, resulting in a concussion |
ACL, anterior cruciate ligament.
Figure 2.Examples of hypothetical prospectively collected injury/illness data (adapted from Finch and Marshall[37]). “X” indicates when a period of surveillance is ended because the athlete left, unrelated to health problems, before the end of the study period; this is called censoring.
Figure 3.Classification tree for subsequent health problems (adapted from Hamilton et al[60]). Definitions: (1) index injury (illness) is the first recorded injury (illness), and (2) subsequent injury (illness) is any injury (illness) occurring after the index injury (illness): (a) subsequent injury to a different location than the index injury (subsequent illness involving a different system than the index illness), (b) subsequent injury to the same location but of a different tissue type than the index injury (subsequent illness involving the same system but of a different type/other diagnosis), or (c) subsequent recurrent injury (illness) is a subsequent injury to the same site and of the same type as the index injury (subsequent illness involving the same system and type as the index illness). Third, fourth, or more health problems should be assessed relative to the initial index health problem and all other previous ones (eg, second and third health problems).
Recommendations for Key Data Items That Should Be Collected and Reported on in Surveillance Systems to Enable Multiple and Subsequent Injuries/Illnesses to Be Monitored
| Data Item | Why It Is Important |
|---|---|
| Unique identifier to link all injuries/illnesses in 1 participant | All participants require a unique identifier that covers all seasons/time periods and should be anonymized to protect privacy and confidentiality. |
| Injury/illness time order sequence | The exact date (day, month, year) of the onset of each health problem is essential for the sequence to be clear. For greater precision, time can be important if there are multiple events/heats each day (eg, swimming). |
| Multiple injury/illness type details | Multiple injuries and illnesses can be the result of different or same events or etiology, coincide at the same time, or a mixture of both. Injuries/illnesses need to be linked to the specific circumstances/events that led to them. Date and time stamping, directly linked to diagnoses of all injuries/illnesses, can inform these relationships. |
| Injury/illness details, including diagnosis | Collect information on the nature, body region/system, tissue/organ, laterality, and diagnosis for all injuries/illnesses. Sport injury/illness diagnostic classification and coding are optimal. |
| Details of circumstances and time elapsed between | The time elapsed between injuries/illnesses will be determined by date and time stamping. If away from participation in sport, then it is important to collect details and date/time stamps regarding rest, rehabilitation, treatment, training, modified sport participation, and return to play. |
Modified from Finch and Fortington.[35]
Recommended Categories of Body Regions and Areas for Injuries
| Body Region/Area | OSIICS | SMDCS | Note |
|---|---|---|---|
| Head and neck | |||
| Head | H | HE | Includes face, brain (concussion), eyes, ears, teeth |
| Neck | N | NE | Includes cervical spine, larynx, major vessels |
| Upper limb | |||
| Shoulder | S | SH | Includes clavicle, scapula, rotator cuff, biceps tendon origin |
| Upper arm | U | AR | |
| Elbow | E | EL | Ligaments, insertional biceps and triceps tendon |
| Forearm | R | FA | Includes nonarticular radial and ulnar injuries |
| Wrist | W | WR | Carpus |
| Hand | P | HA | Includes finger, thumb |
| Trunk | |||
| Chest | C | CH | Sternum, ribs, breast, chest organs |
| Thoracic spine | D | TS | Thoracic spine, costovertebral joints |
| Lumbosacral | L | LS | Includes lumbar spine, sacroiliac joints, sacrum, coccyx, buttocks |
| Abdomen | O | AB | Below diaphragm and above inguinal canal, includes abdominal organs |
| Lower limb | |||
| Hip/groin | G | HI | Hip and anterior musculoskeletal structures (eg, pubic symphysis, proximal adductors, iliopsoas)[ |
| Thigh | T | TH | Includes femur, hamstring (including ischial tuberosity), quadriceps, middistal adductors |
| Knee | K | KN | Includes patella, patellar tendon, pes anserinus |
| Lower leg | Q | LE | Includes nonarticular tibial and fibular injuries, calf, Achilles tendon |
| Ankle | A | AN | Includes syndesmosis, talocrural and subtalar joints |
| Foot | F | FO | Includes toes, calcaneus, plantar fascia |
| Unspecified | Z | OO | |
| Multiple (single injury crossing ≥2 regions) | X | OO |
OSIICS, Orchard Sports Injury and Illness Classification System; SMDCS, Sport Medicine Diagnostic Coding System.
Recommended Categories of Tissue and Pathology Types for Injuries
| Tissue/Pathology Type | OSIICS | SMDCS | Note |
|---|---|---|---|
| Muscle/tendon | |||
| Muscle injury | M | 10.07-10.09 | Includes strain, tear, rupture, intramuscular tendon |
| Muscle contusion | H | 10.24 | |
| Muscle compartment syndrome | Y | 10.36 | |
| Tendinopathy | T | 10.28-10.29 | Includes paratenon, related bursa, fasciopathy, partial tear, tendon subluxation (all nonrupture), enthesopathy |
| Tendon rupture | R | 10.09 | Complete/full-thickness injury; partial tendon injuries considered to be tendinopathy |
| Nervous | |||
| Brain/spinal cord injury | N | 20.40 | Includes concussion and all forms of brain injuries and spinal cord |
| Peripheral nerve injury | N | 20.39, 20.41-20.42 | Includes neuroma |
| Bone | |||
| Fracture | F | 30.13-30.16, 30.19 | Traumatic, includes avulsion fracture, teeth |
| Bone stress injury | S | 30.18, 30.32 | Includes bone marrow edema, stress fracture, periostitis |
| Bone contusion | J | 30.24 | Acute bony traumatic injury without fracture; osteochondral injuries are considered “joint cartilage” |
| Avascular necrosis | E | 30.35 | |
| Physis injury | G | 30.20 | Includes apophysis |
| Cartilage/synovium/bursa | |||
| Cartilage injury | C | 40.17, 40.21, 40.37 | Includes meniscal, labral, articular cartilage, osteochondral injuries |
| Arthritis | A | 40.33-40.34 | Posttraumatic osteoarthritis |
| Synovitis/capsulitis | Q | 40.22, 40.34 | Includes joint impingement |
| Bursitis | B | 40.31 | Includes calcific bursitis, traumatic bursitis |
| Ligament/joint capsule | |||
| Joint sprain (ligament tear or acute instability episode) | L or D | 50.01-50.11 | Includes partial and complete tears plus injuries to nonspecific ligaments and joint capsule; includes joint dislocations/subluxations |
| Chronic instability | U | 50.12 | |
| Superficial tissues/skin | |||
| Contusion (superficial) | V | 60.24 | Contusion, bruise, vascular damage |
| Laceration | K | 60.25 | |
| Abrasion | I | 60.26-60.27 | |
| Vessels (vascular trauma) | V | 70.45 | |
| Stump (stump injury) | W | 91.44 | In amputees |
| Internal organs (organ trauma) | O | 80.46 | Includes trauma to any organ (excluding concussions), drowning, relevant for all specialized organs not mentioned elsewhere (lungs, abdominal and pelvic organs, thyroid, breast) |
| Nonspecific (injury without tissue type specified) | P or Z | 00.00 (also 00.23, 00.38, 00.42) | No specific tissue/pathology diagnosed |
OSIICS, Orchard Sports Injury and Illness Classification System; SMDCS, Sport Medicine Diagnostic Coding System.
Recommended Categories of Illness Symptom Clusters for Athlete Self-reports or Nonmedical Data Reporters
| System/Region | Symptom Cluster |
|---|---|
| Upper respiratory (nose, throat) | Runny nose, congestion, hay fever (allergy), sinus pain, sinus pressure, sore throat, cough, blocked/plugged nose, sneezing, scratchy throat, hoarseness, head congestion, swollen neck glands, postnasal drip (mucus running down the back of the nose to the throat) |
| Lower respiratory | Chest congestion, wheezing (whistling sound), chesty cough, chest pain when breathing/coughing, short of breath, labored breathing |
| Gastrointestinal | Heartburn, nausea, vomiting, loss of appetite, abdominal pain, constipation, weight loss or gain (>5 kg in the past 3 months), change in bowel habits, diarrhea, blood in the stool |
| Cardiovascular | Shortness of breath, racing heart beats, irregular or abnormal heart beats, chest pain, chest pain or discomfort with exercise, dizziness, fainting spells, blackouts, collapse |
| Urogenital/gynecological | Burning urination, blood in urine, loin pain, difficulty in passing urine, poor urine stream, frequent urination, genital sores, loss of normal menstruation, irregular or infrequent menstruation, menstrual cramps/pain, excessively long periods, excessive bleeding during periods, vaginal discharge, penile discharge, swollen groin glands |
| Neurological | Headache, fits or convulsions, muscle weakness, nerve tingling, nerve pain, loss of sensation, chronic fatigue |
| Psychological | Anxiety, nervousness, excessive restlessness, feeling depressed (down), excessive sadness, not sleeping well, mood swings, feeling excessively stressed |
| Dermatological | Skin rash, dark/light/colored areas on the skin that have changed in size or shape, itchy skin lesions |
| Musculoskeletal, rheumatological, and connective tissue (unrelated to injury) | Joint pain, joint stiffness, joint swelling, muscle twitching, muscle cramps, muscle pain, joint redness, warmth in a joint |
| Dental | Toothache, painful gums, bleeding gums, oversensitive teeth, persistent bad breath, cracked or broken teeth, jaw pain, mouth sores |
| Otological | Ear pain, ear discomfort, loss of hearing (new onset), deafness, discharge from the ear canal, bleeding from the ear canal, ringing in the ears |
| Ophthalmological | Pain in eye, itching or burning eye, scratchy eye, eye discharge, change in vision including double vision, blood in eye, excessive tearing, abnormal eye movements, swelling of eye, blind spot in eye, drooping eye, halo around lights, lightning flashes, swelling of eyelid |
| Nonspecific illness | Feeling feverish, chills, pain, whole body aches, feeling tired |
| Energy, load management, and nutrition (nonbody system) | Unexplained underperformance, reduced ability to train and compete, fatigue |
Data on Injury Pattern and Burden of Specific Match Injuries Among Professional Rugby Teams in New Zealand
|
| No. of Injuries | Incidence, Injuries/1000 h (95% CI) | Time Loss, Median (95% CI), d | Burden, Time-Loss Days/1000 h (95% CI) |
|---|---|---|---|---|
|
| 277 | 12.9 (11.5-14.5) | 9 (8-10) | 325 (317-333) |
|
| 204 | 9.5 (8.3-10.9) | 10 (9-11) | 257 (250-263) |
|
| 60 | 2.8 (2.2-3.6) | 8 (6-10) | 135 (130-140) |
|
| 168 | 7.8 (6.7-9.1) | 21 (14-27) | 628 (618-639) |
| Acute dislocation | 15 | 0.7 (0.4-1.1) | 209 (27-337) | 165 (159-170) |
| Hematoma | 18 | 0.8 (0.5-1.3) | 8 (4-13) | 25 (23-27) |
| Joint sprain | 102 | 4.8 (3.9-5.7) | 19 (12-25) | 292 (285-300) |
|
| 54 | 2.5 (1.9-3.3) | 14 (10-20) | 68 (65-72) |
|
| 48 | 2.2 (1.7-2.9) | 30 (14-80) | 225 (218-231) |
|
| 4 | 0.2 (0.1-0.4) | 6 (3-133) | 7 (6-8) |
|
| 27 | 1.3 (0.9-1.8) | 9 (5-17) | 42 (39-44) |
|
| 10 | 0.5 (0.2-0.8) | 99 (44-131) | 65 (61-68) |
|
| 96 | 4.5 (3.6-5.4) | 10 (7-27) | 194 (188-200) |
|
| 81 | 3.8 (3.0-4.7) | 13 (10-16) | 75 (71-79) |
|
| 6 | 0.3 (0.1-0.6) | 5 (3-50) | 5 (4-6) |
|
| 32 | 1.5 (1.0-2.1) | 10 (5-21) | 66 (63-70) |
|
| 6 | 0.3 (0.1-0.6) | 12 (5-20) | 3 (3-4) |
|
| 40 | 1.9 (1.4-2.5) | 9 (6-11) | 82 (78-86) |
|
| 138 | 6.4 (5.4-7.6) | 14 (11-17) | 171 (165-176) |
|
| 165 | 7.7 (6.6-8.9) | 31 (23-37) | 544 (535-554) |
| Knee cartilage injury | 29 | 1.4 (0.9-1.9) | 43 (29-58) | 124 (120-129) |
|
| 22 | 1.0 (0.7-1.5) | 44 (28-62) | 101 (96-105) |
| Knee ligament injury | 125 | 5.8 (4.9-6.9) | 30 (20-37) | 390 (382-398) |
|
| 75 | 3.5 (2.8-4.4) | 33 (24-37) | 154 (149-159) |
|
| 9 | 0.4 (0.2-0.8) | 275 (70-295) | 92 (88-96) |
|
| 6 | 0.3 (0.1-0.6) | 20 (12-218) | 23 (21-25) |
|
| 8 | 0.4 (0.2-0.7) | 35 (7-132) | 55 (52-58) |
|
| 100 | 4.0 (3.2-4.9) | 17 (14-23) | 190 (184-196) |
|
| 147 | 6.9 (5.8-8.0) | 15 (11-21) | 320 (313-328) |
| Ankle sprain | 113 | 5.3 (4.4-6.3) | 15 (11-21) | 228 (222-235) |
|
| 46 | 2.1 (1.6-2.8) | 15 (9-19) | 78 (74-82) |
|
| 34 | 1.6 (1.1-2.2) | 33 (28-43) | 108 (104-112) |
|
| 40 | 1.9 (1.4-2.5) | 37 (14-57) | 84 (80-88) |
From 2005 to 2018 (unpublished data). See also Figure 5, illustrating the same data set in less detail as a risk matrix as well as the sections on rates, severity, and burden of health problems for an explanation of these concepts. ACL, anterior cruciate ligament; LCL, lateral collateral ligament; MCL, medial collateral ligament; PCL, posterior cruciate ligament; PLC, posterolateral corner.
Figure 5.Risk matrix based on the duration of time loss illustrating the burden of match injuries among professional rugby teams in New Zealand between 2005 and 2018 (unpublished data). The darker the yellow, the greater the burden. The curved gray lines represent points with equal burden. The vertical and horizontal error bars represent 95% CIs. See also Table 6, illustrating the same dataset in more detail.
Recommended Categories of Organ System/Region for Illnesses
| Organ System/Region | ICD-11 | OSIICS | SMDCS | Note |
|---|---|---|---|---|
| Cardiovascular | 11 | MC | CV | |
| Dermatological | 14 | MD | DE | |
| Dental | (13) | MT | DT | |
| Endocrinological | 05 | MY | EN | |
| Gastrointestinal | (13) | MG | GI | |
| Genitourinary | 16 | MU | GU | Includes renal, obstetrical, gynecological |
| Hematological | 03 | MH | BL | |
| Musculoskeletal | 15 | MR | MS | Includes rheumatological conditions |
| Neurological | 08 | MN | NS | |
| Ophthalmological | 09 | MO | OP | |
| Otological | 10 | ME | OT | Ear only |
| Psychiatric/psychological | 06 | MS | PS | |
| Respiratory | 12 | MP | RE | Includes nose and throat |
| Thermoregulatory | (22) | MA | TR | |
| Multiple systems | MX | MO | ||
| Unknown or not specified | MZ | UO |
ICD-11, International Classification of Diseases–11th Revision; OSIICS, Orchard Sports Injury and Illness Classification System; SMDCS, Sport Medicine Diagnostic Coding System.
Recommended Categories for Etiology of Illnesses
| Etiology | ICD-11 | OSIICS | SMDCS | Note |
|---|---|---|---|---|
| Allergic | (22) | MxA | 71 | |
| Environmental (exercise related) | (23) | MxE | 72 | Heat illness, hypothermia, hyponatremia, dehydration |
| Environmental (nonexercise) | (22/7) | MxS | 73 | Includes sleep/wake, sunburn |
| Immunological/inflammatory | (04) | MxY | 74 | |
| Infection | 01 | MxI | 75 | Viral, bacterial, parasitic |
| Neoplasm | 02 | MxB | 76 | |
| Metabolic/nutritional | 05 | MxN | 77 | |
| Thrombotic/hemorrhagic | (11/03) | MxV | 78 | |
| Degenerative or chronic condition | — | MxC | 79 | Chronic acquired conditions |
| Developmental anomaly | 20 | MxJ | 80 | Includes congenital conditions |
| Drug-related/poisoning | 22 | MxD | 81 | Includes pharmaceutical, illicit |
| Multiple | MxX | 82 | ||
| Unknown or not specified | MxZ | 83 |
ICD-11, International Classification of Diseases–11th Revision; OSIICS, Orchard Sports Injury and Illness Classification System; SMDCS, Sport Medicine Diagnostic Coding System.
Practical Examples of How to Calculate Time Loss
| Case | Time Loss, d |
|---|---|
| A collegiate volleyball player is substituted from a match because of an injury but returns to compete in another match later the same day. | 0 |
| A cyclist interrupts a training session because of mild diarrhea and resumes normal training the following day. | 0 |
| A hockey player strains her hamstring during a training session on Monday and returns to normal training on Monday of the following week. | 6 |
| A recreational-level cricket player injures his shoulder during a match on Saturday. His shoulder is stiff and painful for 2 days after the match (Sunday and Monday). The team only trains once per week, every Thursday, but the player feels that he would have been able to train normally had training been on Tuesday instead. | 2 |
| “Delayed” time loss: An athlete suffers an injury on Sunday, a thigh contusion, is able to train on Monday and Tuesday, but is unable to train on Wednesday and returns on Sunday (time loss starts on Wednesday, even though the injury occurred on Sunday). | 3 |
| “Intermittent” time loss: A player with Osgood-Schlatter disease that gets reported at the start of a training camp on Monday. He may train fully on Monday, Tuesday, and Thursday but miss training on Wednesday and Friday (time loss counted as Wednesday and Friday only). | 2 |
Figure 4.Example of severity scores being used to track the severity of 3 “typical” health problems. Each black dot represents the weekly severity score. The area in orange represents a gradual-onset injury (cumulative severity score [sum of weekly scores, as the area under the curve] = 1820), the black area represents a short-duration illness (score = 100), and the dark red area represents an acute medial collateral ligament injury (score = 362).[17]
Figure 6.Risk matrix based on Oslo Sports Trauma Research Center Questionnaire on Health Problems severity scores illustrating the burden of injuries and illnesses affecting elite Norwegian endurance athletes (unpublished data). Error bars represent 95% CIs.
Implementation Recommendations for Injury/Illness Surveillance
| The implementation of an injury and illness surveillance project should include the following aspects: |
|---|
| Methods based on this consensus statement on definitions and data collection procedures |
| Mandatory standards for compliance with defined time scales for completion for report forms |
| Guidance document (a quality protocol) shared with all club/national team medical staff (preseason/tournament) |
| Regular contact between study lead and responsible person at each club/national team (face-to-face meeting preseason/prior to tournament, conference call midseason/tournament) |
| All injuries cross-checked with club/team medical records and followed up with medical staff for missing, incomplete, inconsistent, or duplicate entries (regularly during season/tournament) |
| Data cleaning and final review of dataset with responsible person at each club/team before definitive analysis (end of season/tournament) |
| Injury reports where individual club/team data are reported, analyzed, and compared with the average of all participating clubs/teams (midseason and end of season/tournament) |
| Medical meeting (end of season/tournament) where whole surveillance results and translational value are presented to club/team medical practitioners for discussion |
Injury Rates to Ball Carriers in Rugby Tackles
| Injuries Requiring Player to Be Removed From Match | ||||
|---|---|---|---|---|
| Tackle Height | Tackles per Match | Per 10,000 Tackles | Per 10,000 Player-Hours | Percentage of Injuries per 10,000 Player-Hours |
| Head/neck | 4 ± 2 | 43 (23-79) | 4 (2-8) | 13 (7-23) |
| High | 37 ± 10 | 12 (8-17) | 11 (8-16) | 36 (26-47) |
| Middle | 44 ± 9 | 9 (6-13) | 10 (7-15) | 32 (23-43) |
| Low | 15 ± 5 | 16 (9-26) | 6 (3-10) | 19 (12-29) |
Rates are expressed via event- and time-based denominators. Data are shown as mean ± standard deviation or mean (range).
A Range of Exposure and Risk Measures Derived From Injury Surveillance Data
| Statistic | Value | Calculation | Explanation | Comment |
|---|---|---|---|---|
| Injury statistics | ||||
| No. of injuries (carrier injury replacements in 434 matches) | 53 | Nil | Count of the number of tackler injuries requiring the injured player to be replaced observed in 434 matches | The “numerator” used for calculating the rate of tackler replacement injuries per unit of time or per tackle. Absolute numbers and costs of injuries are of interest to risk managers, especially when provided in parallel with rates. |
| No. of injured players (some were injured more than once) | 48 | Nil | This is the numerator for calculating injury risk. | |
| Exposure measures | ||||
| Player-hours in 434 matches | 17,360 | 30 × 579 | 30 players (15 from each team) multiplied by 579 (hours of play in 434 matches of 80 minutes’ duration) | This number provides a “time-window” denominator. Usually, it is assumed that time lost for yellow and red cards, or time gained for “extra time,” is negligible and is ignored. |
| No. of single-tackler tackle events in 434 matches | 43,366 | Nil | All tackles in 434 matches were coded, regardless of whether they resulted in injury | This number forms an “event-based” denominator. |
| No. of players who appeared in the 434 matches | 1403 | Nil | This is a count of the size of the cohort across the entire study period. It is used as the denominator for calculating injury risk. | |
| No. of full player matches | 13,020 | 30 × 434 | 30 players (15 from each team) multiplied by 434 matches | This number provides a “per-match” denominator. |
| No. of athlete-exposures (athlete-participations) | 17,685 | Nil | Count of the number of players who took the field over 434 matches (players can be substituted for tactical purposes or replaced due to injury) | The similarity to the number of player-hours is coincidental. There are 40 hours of player time per match, and the average number of athlete-exposures per match over this series of matches was 40.8. |
| Risk measures | ||||
| Period prevalence (percentage of cohort injured) | 3% | (48/1403) × 100 | Percentage of people who appeared in matches who were replaced | Often reported as the “risk per season” or “risk per year.” It cannot be easily used to compare between activities if the duration of surveillance varies from activity to activity. The longer the surveillance period, the higher the risk will appear to be for closed cohorts. |
| Injuries per 1000 player-hours | 3.1 | (53/17,360) × 1000 | Number of injuries is divided by the number of hours of player exposure and multiplied by a scaling factor (eg, 1000, 10,000) to provide a rate that is convenient to work with (eg, numbers in the range of 1 to 1000 rather than numbers <0 or >1000) | The most commonly reported metric of injury rates in studies of rugby injury epidemiology has been the rate of injuries per 1000 player-hours. This convention is endorsed in the consensus statement by Fuller et al.[ |
| Injuries per 1000 matches | 122 | (53/434) × 1000 | Rate of tackler replacements per rugby union match multiplied by 1000; rate per match multiplied by a factor that provides a convenient interpretation (0.12 carrier replacement injuries per match, 12.2 per 100 matches, 122 per 1000 matches, etc) | Ignores the number of players and match duration and provides an estimate of the number of injuries that an observer would expect to see if they watched 1000 matches. Not useful for comparing incidence rates between activities of differing durations or numbers of participants. |
| Injuries per 1000 hours of play (ignoring number of players) | 92 | (53/579) × 1000 | Rate per hour is multiplied by a factor that provides a convenient interpretation (0.9 carrier replacement injuries per hour, 9.2 per 100 hours, 92 per 1000 hours, etc) | Ignores number of players and provides an estimate of the number of injuries an observer would expect to see if they watched 1000 hours of play. Not useful for comparing between activities with differing numbers of participants because the sizes of the populations at risk differ. |
| Injuries per 1000 athlete-exposures (athlete-participations) | 3.0 | (53/17,685) × 1000 | Carrier injury replacements per 1000 athlete-exposures | Injuries per 1000 athlete-exposures are commonly reported in injury surveillance in the United States. Problematic for comparing between activities that have different numbers of typical athlete-exposures per match or when the average exposure time per player changes over time. |
| Injuries per 1000 full player matches | 4.1 | (53/13,020) × 1000 | Not commonly used. It ignores the duration of the match and, as such, has similar drawbacks to reporting injuries per athlete-exposure because the time window of exposure varies between activities of different durations. | |
| Injuries per 1000 “ball in play” player-hours | 6.8 | (53/7740) × 1000 | Not commonly used but technically a more accurate measure of exposure than injuries per 1000 player-hours because players are only exposed to tackles when the ball is “in play.” | |
| Injuries per 1000 “ball in play and ball carrier’s team in possession” player-hours | 13.5 | (53/3819) × 1000 | Again, not commonly used but an even closer approximation of the actual time exposed to the risk of ball carrier injuries. Players are only tackled when the ball is in play and their team is in possession. | |
| Injuries per 1000 tackle events | 1.2 | (53/43,366) × 1000 | Ball carrier injury replacements per 1000 times tackled | Provides an accurate assessment of per-event injury rates but in isolation ignores the frequency of occurrence of the event of interest. Injury rates per event have sometimes been termed “injury propensity.”[ |
| Injuries per 1000 players per year | 24 | ([23 + 17 + 13] × 1000) / (983 + 589 + 627) | Sometimes provided as a gross estimate of the injury risk when participant numbers and injury numbers are available but no measure of exposure for players is available (eg, data derived from insurance claims combined with registers of participants). Of limited use when exposure varies by subgroup or across sports. | |
Examples from a study of rugby tackle injuries.[87]
Checklist of Items for Reporting Observational Studies on Injury and Illness in Sports
| Item | Recommendation From STROBE Statement | STROBE-SIIS Extension | Source of Rationale for Item From Consensus Statement and Where to Find Further Details |
|---|---|---|---|
| (1) Title and abstract | (a) Indicate the study’s design with a commonly used term in the title or abstract | ||
| (b) Provide in the abstract an informative and balanced summary of what was done and what was found | SIIS 1.1: Include information on the sport, athlete population (sex, age, geographic region), and level of competition | SIIS 1.1: “Study population characteristics” | |
| Introduction | |||
| (2) Background/rationale | Explain the scientific background and rationale for the investigation being reported | ||
| (3) Objectives | State specific objectives, including any prespecified hypotheses | SIIS 3.1: State whether study was registered. Identify the registration number and database used | SIIS 3.1: “Reporting guidelines: STROBE Sports Injury and Illness Surveillance (STROBE-SIIS)” |
| Methods | |||
| (4) Study design | Present key elements of study design early in the paper | SIIS 4.1: Clearly specify which health problems are being observed | SIIS 4.1: “Defining and classifying health problems” |
| (5) Setting | Describe the setting, locations, and relevant dates, including periods of recruitment, exposure, follow-up, and data collection | SIIS 5.1: Describe the location, level of play, dates of observation, and data collection methods (ie, who, what, where) | SIIS 5.1: “Study population characteristics” |
| (6) Participants | (a) | SIIS 6.1: Define the population of athletes as well as describe how they were selected and recruited | SIIS 6.1: “Data collection methods” and “Study population characteristics” |
| (b) | |||
| (7) Variables | Clearly define all outcomes, exposures, predictors, potential confounders, and effect modifiers. Give the diagnostic criteria, if applicable | SIIS 7.1: Justify why you measured your primary and secondary outcomes of interest in the specific way chosen | SIIS 7.1: “Defining and classifying health problems” |
| (8) Data sources/measurement | For each variable of interest, give sources of data and details of methods of assessment (measurement). Describe comparability of assessment methods if there is more than 1 group | SIIS 8.1: Specify who collected/reported the data for the study and their qualifications (eg, qualified doctor, data analyst, etc) | SIIS 8.1: “Classifying sports injury and illness diagnoses” and “Data collection methods” |
| (9) Bias | Describe any efforts to address potential sources of bias | SIIS 9.1: Clearly report any validation or reliability assessment of the data collection tools | SIIS 9.1: “Data collection methods” |
| (10) Study size | Explain how the study size was arrived at | ||
| (11) Quantitative variables | Explain how quantitative variables were handled in the analyses. If applicable, describe which groupings were chosen and why | SIIS 11.1: Explain in detail how multiple injuries/illness episodes are handled both in individual athletes and across athletes/surveillance periods | SIIS 11.1: “Multiple events and health problems” and “Subsequent, recurrent, and/or exacerbation of health problems” |
| (12) Statistical methods | (a) Describe all the statistical methods, including those used to control for confounding | SIIS 12.1: Specify how the exposure to risk has been adjusted for and specify units (eg, per participant, per athlete-exposure, etc) | SIIS 12.1: “Capturing and reporting athlete-exposure” |
| (b) Describe any methods used to examine subgroups and interactions | |||
| (c) Explain how missing data were addressed | SIIS 12.4: For studies reporting multiple health problems, state clearly how these were handled (eg, time to the first injury only, ignoring subsequent return to play and reinjuries, or modeling of all injuries) | SIIS 12.4: “Multiple health problems” and “Subsequent, recurrent, and/or exacerbation of injury/illness” | |
| (d) | SIIS 12.6: In longitudinal studies, it is particularly important to explain how athlete follow-up has been managed. For example, what happened if a player was trasferred to another team or has been censored (for those no longer part of the study due to removal during the observation period). Censoring can occur when athletes are removed due to transfer out of the team/study, injury/illness, or due to study design]) | SIIS 12.6: “Capturing and reporting athlete-exposure” | |
| (e) Describe any sensitivity analyses | |||
| Results | |||
| (13) Participants | (a) Report numbers of individuals at each stage of study (eg, numbers potentially eligible, examined for eligibility, confirmed eligible, included in the study, completing follow-up, and analyzed) | SIIS 13.1: Clearly state the number of athletes who were followed up, the number (and percentage) of those with the health problem, and the number of problems reported among them (a median number of problems per affected athlete could be useful) | SIIS 13.1: “Multiple health problems” |
| (b) Give the reasons for nonparticipation at each stage | SIIS 13.3: Report how athletes who were removed (eg, because of the transfer of teams or timeout due to an injury or illness) impact the data at key data collection/reporting points, ideally with a flow diagram | SIIS 13.3: Throughout the consensus statement | |
| (14) Descriptive data | (a) Give the characteristics of study participants (eg, demographic, clinical, social) and information on exposures and potential confounders | SIIS 14.1: Include details on the level of competition being observed (eg, by age level, skill level, sex, etc) | SIIS 14.1: “Study population characteristics” |
| (b) Indicate number of participants with missing data for each variable of interest | |||
| (c) | |||
| (15) Outcome data |
| SIIS 15.1: In observational studies, individuals will sustain more than one health problem over the surveillance period. Take care to ensure that descriptive data represent both the number of health problems and the number of athletes affected. It is important to represent effectively both the analysis and reporting of correct units for frequency data (ie, the percentage of affected athletes or percentage of injuries, body regions, etc) | SIIS 15.1: “Multiple health problems” and “Subsequent, recurrent, and/or exacerbation of injury/illness” |
|
| |||
|
| |||
| (16) Main results | (a) Give unadjusted estimates and, if applicable, confounder-adjusted estimates and their precision (eg, 95% confidence interval). Make clear which confounders were adjusted for and why they were included | SIIS 16.1: Report exposure-adjusted incidence or prevalence measures with appropriate confidence intervals when presenting risk measures | SIIS 16.1: “Expressing risk” |
| (b) Report category boundaries when continuous variables were categorized | |||
| (c) If relevant, consider translating estimates of relative risk into absolute risk for a meaningful time period | |||
| (17) Other analyses | Report other analyses done (eg, analyses of subgroups and interactions and sensitivity analyses) | SIIS 17.1: Report injury diagnosis information, including region and tissue type in tabular form | SIIS 17.1: “Defining and classifying health problems” |
| Discussion | |||
| (18) Key results | Summarize key results with reference to study objectives | ||
| (19) Limitations | Discuss the limitations of the study, taking into account the sources of potential bias or imprecision. Discuss both the direction and magnitude of any potential bias | SIIS 19.1: Discuss limitations in the data collection and coding procedures adopted, including in relation to any risk measures calculated | SIIS 19.1: “Data collection methods” and “Expressing risk” |
| (20) Interpretation | Give a cautious overall interpretation of results, considering objectives, limitations, multiplicity of analyses, results from similar studies, and other relevant evidence |
| |
| (21) Generalizability | Discuss the generalizability (external validity) of the study results | SIIS 21.1: Discuss the generalizability of the athlete study population, and health problem subgroups of interest, to broader athlete groups | SIIS 21.2: “Relationship to sports activity” and “Study population characteristics” |
| Other information | |||
| (22) Funding | Give the source of funding and the role of the funders for the present study and, if applicable, for the original study on which the present article is based | ||
| (23) Ethics | SIIS 23.1: Outline how individual athlete data privacy and confidentiality considerations were addressed, in line with the Declaration of Helsinki | SIIS 23.1: “Research ethics and data security” | |
The STROBE-SIIS checklist with additional sports epidemiology annotations should be used in conjunction with the original STROBE statement (freely available on the websites of PLoS Medicine at http://www.plosmedicine.org/, Annals of Internal Medicine at http://www.annals.org/, and Epidemiology at http://www.epidem.com/). Information on the STROBE initiative is available at www.strobe-statement.org. The term “health problem” is used to encompass both injury and illness. Where there is a blank cell, there are no specific additional reporting requirements for sports injury and illness surveillance over what is already covered in the original STROBE checklist.
Give information separately for cases and controls in case-control studies and, if applicable, for exposed and unexposed groups in cohort and cross-sectional studies.